India Globalization Capital Inc

Stock Chart, Company Information, and Scan Results

$0.32(as of Apr 30, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

India Globalization Capital Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$0.32
Ticker SymbolIGC
ExchangeNyse Mkt
SectorHealthcare
IndustryBiotechnology
Employees70
CountyUSA
Market Cap$30.6M

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.

India Globalization Capital Inc In Our Stock Scanner

As of May 01, 2026
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.